Health Care: Drugs

Sucampo Pharmaceuticals Inc (SCMP: NASDAQ)

$6.2 -0.05 | -0.8%
07/25/14 - 03:21 PM ET
Company Profile
Price and Volume
Recent Price 6.25
52 Week High 11.00
52 Week Low 5.40
Avg. Daily Vol. (Mil) 0.13
Beta (3 year) 1.82
Share Related Items
Mkt Cap (Mil) 276.61
Shares Out (Mil) 44.26
Float (Mil) 14.89
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.10
Current Ratio 2.80
LT Debt/ Equity 0.39
Total Debt / Equity 0.81
Valuation Ratios
Price Earnings 26.10
Price/Sales 2.92
Price/Book 4.23
Price/Cash Flow 23.40
Per Share Data
Earnings 0.24
Sales 2.14
Book Value 1.48
Cash Flow 0.27
Business Summary
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company engaged in research, development & sale of proprietary drugs based on ion channel activators known as prostones to treat gastrointestinal, neurologic, & oncology-based inflammatory disorders.
General Information
4520 East-West Highway
3rd Floor
Bethesda, MD 20814
www.sucampo.com
Industry : Drugs
Sector: Health Care
Employees: 77
CEO: Mr. Peter Greenleaf
Short Interest
Current Month (Mil) 2.19
Previous Month (Mil) 2.08
Short Interest Ratio (Days) 17.70
Management Effectiveness
Return on Equity 15.70
Return on Assets 7.10
Return on Investments 11.20
Profitability
Gross Margin 86.20
EBIT Margin 17.00
Profit Margin 10.80

Portfolios with SCMP

Latest SCMP Headlines from TheStreet

More Financial News for SCMP

Press Releases for SCMP

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter